CHNQD-03005 is an orally active anti-inflammatory agent. CHNQD-03005 inhibits the expression of iNOS and COX-2, reduces inflammatory signal transduction, suppresses NO production, and downregulates the pro-inflammatory cytokines TNF-alpha, IL-6 and IL-1beta. CHNQD-03005 can be used in the research of inflammatory diseases such as colitis[1].
Molekulargewicht:
512.55
Formel:
C31H28O7
Target-Kategorie:
COX,Interleukin Related,NO Synthase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
